RxDoctor Payments Data

Taro Adachi, MD

Gynecology · Frederick, MDNPI 1376638213

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.8% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $136 and has fallen 58.6% since, to $56 in 2025. That places this record below the midpoint for gynecology clinicians in MD, where the typical reported total is $794.

$542in general payments, 2019–2025

Across 28 payments — averaging $19.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$109
  • Astellas Pharma US Inc$48
  • Alydia Health$43
  • Therapeuticsmd, Inc.$43
  • Sage Therapeutics, LLC$39
  • Sumitomo Pharma America, Inc.$35
  • plus $226 from 11 others

What the payments were for

  • Food & beverage$51996%
  • Education$234%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$542 in reported general payments places this provider in the 45th percentile of 79 gynecology providers in Maryland.

See all gynecology providers in Maryland

Medicare billing

Part B allowed, 2024
$10,197
Medicare patients
42
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol14$1,629

Paid to pharmacies, not to this prescriber.

Other gynecology in Frederick

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →